Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Schering-Plough and PTC Therapeutics establish HCV collaboration

March 22, 2006

EG-S21 studied for Crohn's disease in new phase II trial

March 21, 2006

Entecavir superior to lamivudine in HBeAg-positive and -negative hepatitis B

March 21, 2006

Human Genome Sciences reports new phase II data for Albuferon

March 20, 2006

Significant decline in HBV viral load in pradefovir study

March 20, 2006

AT-1001 completes phase Ib in celiac disease patients

March 15, 2006

Anti-HCV drugs prepared and tested at Bristol-Myers Squibb

March 14, 2006

European approval for Remicade for ulcerative colitis

March 10, 2006

Positive results for Zegerid in nocturnal acid breakthrough

March 10, 2006

Oral NV-52 demonstrates rapid absorption and appreciable plasma levels

March 6, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...